BnR Summit 2025

Belt and Road Summit 2025- Deal-making

10 – 16 Sept 2025 | China (Hong Kong)

ProjectUpdated on 3 September 2025

Q-Velox Fully Automated PCR Diagnostic System

Hoi Yee Chow

COO at Serilink Biotechnology Company Limited

Hong Kong, China (Hong Kong)

About

Q-Velox is a fully automated, real-time PCR based molecular diagnostic system with all-in-one disposable cartridge. The fully enclosed cartridge contains an unique sample preparation system and a separate reaction chamber, and comes with all reagents pre-loaded on board. Completely automated sample preparation and real-time quantitative PCR reaction and detection are performed by the Q-Velox, reducing operator hands-on time, reducing time to results, eliminating human error and cross-contamination, and improving test accuracy.

Project Location

  • China

Project Format

  • Private Project

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Operations

Main Project Sector

  • Technology

Technology

  • Bio-Tech
  • Health Technology
  • Medical Technology

Total Project Value

  • 25,000,001 to 50,000,000 USD

Investment Capital Required

  • 500,001 to 1,000,000 USD

Interested Format of Cooperation

  • Joint Venture
  • Minority Shareholdings
  • Open for Negotiation
  • Public–private partnership / Concession
  • R&D Cooperation

Preferred Financing Model

  • Equity
  • Open for negotiation

Previous Funding Stage

  • Series B

Main Service(s) Required

  • Financial Services
  • Professional Services

Financial Services

  • Institutional Investment
  • Mergers & Acquisition
  • Private Equity & Venture Capital

Professional Services

  • Financial Advisory
  • Market Entry Strategic Analysis

Organisation

Serilink Biotechnology Company Limited

Hong Kong, China (Hong Kong)

Similar opportunities